Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution. (Q39508657)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ting-Tung Chang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

William T Phillips

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ande Bao

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Beth Goins

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

5 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

Journal of Liposome Research

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

70-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23210622%20AND%20SRC:MED&resulttype=core&format=json

Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Direct 99mTc Labeling of Pegylated Liposomal Doxorubicin (Doxil) for Pharmacokinetic and Non-Invasive Imaging Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

A novel non-toxic camptothecin formulation for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Direct evidence of multicompartment aggregates in polyelectrolyte-charged liposome complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Liposomes as drug carriers: a technological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Development of a highly stable and targetable nanoliposomal formulation of topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Cationic lipid complexed camptothecin (EndoTAG-2) improves antitumoral efficacy by tumor vascular targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Lipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

9-nitrocamptothecin liposome aerosol: lack of subacute toxicity in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Quantification of various phosphatidylcholines in liposomes by enzymatic assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Chronic ethanol induces inhibition of antigen-specific CD8+ but not CD4+ immunodominant T cell responses following Listeria monocytogenes inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Camptothecin delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Targeted liposomal drug delivery to monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Enhanced therapeutic efficacy of a novel liposome-based formulation of SN-38 against human tumor models in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: stability, pharmacokinetic and therapeutic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Artificial lipids stabilized camptothecin incorporated in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Differential interactions of camptothecin lactone and carboxylate forms with human blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

21 January 2018

Radioactive liposomes

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Effective prodrug liposome and conversion to active metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Effect of CPT‐11 on Lipid Peroxide Level in Mouse Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Liposomalization of SN-38 as active metabolite of CPT-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Cytotoxic effect of different camptothecin formulations on human colon carcinoma in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

A method to determine the incorporation capacity of camptothecin in liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Bone marrow-targeted liposomal carriers: a feasibility study in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Cyclodextrins: their future in drug formulation and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Determination of subcutaneous tumor size in athymic (nude) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Development and characterization of a novel liposome-based formulation of SN-38.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Preparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537

Doubly radiolabeled liposomes for pretargeted radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2012.742537